Five years after their wide deployment, first on a voluntary basis, then under threat of firing for nearly 100 million Americans at the direction of the White House, COVID-19 vaccines for at least low-risk groups may be on the way out amid higher regulatory requirements and indifference to the jabs by the vast majority of Americans.
‘Humiliating’: Pfizer cancels COVID vaccine trial for lack of interest as global scrutiny mounts
